Er zijn situaties waarin GLP-1 middelen worden afgeraden
GLP-1 medications, or glucagon-like peptide-1 receptor agonists, treat type 2 diabetes and, in some cases, obesity
While this has brought about considerable backlash, do these injections under the brands, Ozempic, Mo and more, actually deliver results
Understanding what to expect can help patients and clinicians manage the transition appropriately
LDL cholesterol reductions of approximately 20% occurred consistently across studies, likely reflecting enhanced hepatic cholesterol clearance through glucagon-mediated upregulation of LDL receptors
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice